SCHEMBL17599525

SCHEMBL17599525

Cc1cc(C)c(C)c(S(=O)(=O)Nc2ccc(C(CC(=O)O)c3ccccc3)c3ccccc23)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.51
▸ MEN1 O00255 5/20 0.51
▸ KDM4E B2RXH2 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ HPGD P15428 3/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ CRHBP P24387 1/20 0.51
▸ CRHR2 Q13324 1/20 0.51
▸ KEAP1 Q14145 7/20 0.49
▸ NFE2L2 Q16236 3/20 0.49
▸ GAA P10253 3/20 0.40
▸ TSHR P16473 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ G6PD P11413 2/20 0.39
▸ HKDC1 Q2TB90 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599546 0.87 MEN1 (0.45) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599526 0.82 ALDH1A1 (0.53) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL25057908 0.74 KEAP1 (0.45) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL28407007 0.74 KEAP1 (0.45) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599363 0.72 MEN1 (0.53) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599329 0.70 KMT2A (0.55) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599549 0.70 KEAP1 (0.42) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599545 0.70 ALDH1A1 (0.47) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599536 0.70 KDM4E (0.47) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL17599352 0.70 ALDH1A1 (0.63) KMT2AMEN1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback